The results of CD34 staining by IHC showed that the MVD levels both in IPN group and cisplatin-IPN group were notably lower than that from negative control at 4 weeks after tumor implantation (Figure 4(A)), suggesting TPVE treatment down-regulated tumor angiogenesis. The gene discussed is CD34; the disease is neoplasm.